Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
denosumab (prolia) (1 trial)
ranibizumab (lucentis) (1 trial)
teriparatide (2 trials)
tofacitinib (xeljanz) (2 trials)
abatacept (orencia) (1 trial)
baricitinib (olumiant) (1 trial)
bazedoxifene (Duavee) (1 trial)
eldecalcitol (2 trials)
esomeprazole (nexium) (1 trial)
ibandronate (boniva) (1 trial)
metformin (glucophage) (1 trial)
sarilumab (kevzara) (1 trial)
tocilizumab (actemra) (1 trial)
tofogliflozin hydrate (1 trial)
vitamin d3 (2 trials)
vonoprazan (Voquezna) (1 trial)
zoledronic acid (zometa) (1 trial)
propiverine hydrochloride (1 trial)
Arthritis (Phase 4)
Arthritis, Rheumatoid (Phase 4)
Edema (Phase 4)
Osteoporosis (Phase 4)
Ulcer (Phase 2)
Trials (13 total)
Trial APIs (18 total)